Apyx Medical Corporation (APYX) is priced at $1.72 after the most recent trading session. At the very opening of the session, the stock price was $1.40 and reached a high price of $1.72, prior to closing the session it reached the value of $1.40. The stock touched a low price of $1.38.Recently in News on November 22, 2022, Apyx Medical Corporation to Participate in the Piper Sandler 34th Annual Healthcare Conference. Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, announced today that management will participate in the Piper Sandler 34th Annual Healthcare Conference, which is being held at the Lotte New York Palace in New York, NY. Management will participate in fireside chat on Wednesday, November 30 at 11:00 a.m. ET. You can read further details here
Apyx Medical Corporation had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $13.7799 on 01/03/22, with the lowest value was $1.3100 for the same time period, recorded on 11/18/22.
Apyx Medical Corporation (APYX) full year performance was -89.91%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Apyx Medical Corporation shares are logging -90.16% during the 52-week period from high price, and 31.30% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.31 and $17.48.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 448594 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Apyx Medical Corporation (APYX) recorded performance in the market was -86.58%, having the revenues showcasing -73.00% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 57.48M, as it employees total of 272 workers.
The Analysts eye on Apyx Medical Corporation (APYX)
During the last month, 0 analysts gave the Apyx Medical Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.9029, with a change in the price was noted -4.42. In a similar fashion, Apyx Medical Corporation posted a movement of -71.99% for the period of last 100 days, recording 252,555 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for APYX is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Apyx Medical Corporation (APYX)
Raw Stochastic average of Apyx Medical Corporation in the period of last 50 days is set at 8.05%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 10.28%. In the last 20 days, the company’s Stochastic %K was 5.10% and its Stochastic %D was recorded 3.54%.
Considering, the past performance of Apyx Medical Corporation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -86.58%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -53.51%, alongside a downfall of -89.91% for the period of the last 12 months. The shares increased approximately by 13.91% in the 7-day charts and went up by -60.00% in the period of the last 30 days. Common stock shares were lifted by -73.00% during last recorded quarter.